COMPANY PRODUCT TYPE THERAPEUTIC AREA INDICATION PHASE STUDIES LOCATION PRODUCT
Ability Pharmaceuticals ABTL0815 Biodrugs/ Drugs Cancer Solid Tumors 1NRP ABTL0815
Therapeutic area: Cancer
Ability Pharmaceuticals ABTL0812 Biodrugs/ Drugs Cancer Lung, Endometrial and Pancreatic Cancer 4PhII ABTL0812
Therapeutic area: Cancer
Almirall Terbinafine, ALM12834 Biodrugs/ Drugs Dermatology Onychomycosis 6Reg. Terbinafine, ALM12834
Therapeutic area: Dermatology
Almirall Finasteride, ALM12845 Biodrugs/ Drugs Dermatology Androgenetic Alopecia 6Reg. Finasteride, ALM12845
Therapeutic area: Dermatology
Almirall Tirbanibulin, ALM14789 Biodrugs/ Drugs Dermatology Actinic keratosis 6Reg. Tirbanibulin, ALM14789
Therapeutic area: Dermatology
Almirall Lebrikizumab Biodrugs/ Drugs Autoimmune & Inflammation
Dermatology
Atopic dermatitis 5PhIII Lebrikizumab
Therapeutic area: Autoimmune & Inflammation
Dermatology
Almirall BNZ-01 Biodrugs/ Drugs Cancer
Dermatology
Refractory cutaneous T-cell lymphoma 4PhII BNZ-01
Therapeutic area: Cancer
Dermatology
Aptatargets ApTOLL-01 Biodrugs/ Drugs Cardiovascular and circulatory systems
Central Nervous System
Acute ischemic stroke Acute coronary syndrome 3PhI ApTOLL-01
Therapeutic area: Cardiovascular and circulatory systems
Central Nervous System
Aptatargets ApTOLL-03 Biodrugs/ Drugs Autoimmune & Inflammation Multiple Sclerosis 1NRP ApTOLL-03
Therapeutic area: Autoimmune & Inflammation
APTUS Biotech AptaMnk Biodrugs/ Drugs Cancer Breast cancer treatment based on aptamers 1NRP AptaMnk
Therapeutic area: Cancer
Araclon Biotech ABvac40 Biodrugs/ Drugs Central Nervous System Alzheimer's Disease 4PhII ABvac40
Therapeutic area: Central Nervous System
Archivel Farma RUTI Vaccines Infections Safety of RUTI® Vaccination in MDR-TB Patients 4PhII Ucrania RUTI
Therapeutic area: Infections
Archivel Farma RUTI Vaccines Cancer Bladder cancer. 3PhI RUTI
Therapeutic area: Cancer
Archivel Farma RUTI Vaccines Infections Clinical Trial to Evaluate the Efficacy of RUTI® Against SARS- COV-2 Infection in Healthcare Workers 2RP Spain RUTI
Therapeutic area: Infections
Archivel Farma RUTI® Vaccines Infections Active tuberculosis - Latent Tuberculosis 4PhII Europe and South Africa RUTI®
Therapeutic area: Infections
Arthex Biotech ARTHEx-01 Biodrugs/ Drugs Genetic Diseases and Dysmorphic syndromes
Musculoskeletal Disorders
Myotonic dystrophy type 1 (DM1) 1NRP ARTHEx-01
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
Musculoskeletal Disorders
ATRYS HEALTH NILO1 Biodrugs/ Drugs Cancer
Central Nervous System
Brain tumor and brain lesions 1NRP Spain NILO1
Therapeutic area: Cancer
Central Nervous System
Bioibérica Droglican Biodrugs/ Drugs Musculoskeletal Disorders Symptomatic treatment of knee osteoarthritis 6Reg. Spain Droglican
Therapeutic area: Musculoskeletal Disorders
Bioibérica Hialsorb intra-articular injection Biodrugs/ Drugs Musculoskeletal Disorders Indicated for treatment of degenerative or mechanical joint diseases 6Reg. Spain Hialsorb intra-articular injection
Therapeutic area: Musculoskeletal Disorders
Bioibérica Cartisorb Biodrugs/ Drugs Musculoskeletal Disorders Symptomatic treatment of osteoarthritis 6Reg. Spain Cartisorb
Therapeutic area: Musculoskeletal Disorders
Bioibérica Duartron Biodrugs/ Drugs Musculoskeletal Disorders Alleviation of mild to moderate osteoarthritis of the knee 6Reg. Duartron
Therapeutic area: Musculoskeletal Disorders
Bioibérica Condrosan Biodrugs/ Drugs Musculoskeletal Disorders Symptomatic treatment of osteoarthritis 6Reg. Spain Condrosan
Therapeutic area: Musculoskeletal Disorders
Bioibérica BIS014 Biodrugs/ Drugs Analgesia & Pain
Central Nervous System
Neuropathic pain 2RP Europe BIS014
Therapeutic area: Analgesia & Pain
Central Nervous System
Bionure BN201 Biodrugs/ Drugs Central Nervous System
Ophthalmology and optometry
Acute Optic Neuritis, Neuromyelitis Optica, Multiple Sclerosis 3PhI BN201
Therapeutic area: Central Nervous System
Ophthalmology and optometry
DIOMUNE SL IV1303 Biodrugs/ Drugs Autoimmune & Inflammation
Cardiovascular and circulatory systems
Genetic Diseases and Dysmorphic syndromes
Infections
Sepsis treatment, Stroke, Rare diseases (CDH), Leishmania, ZIKV 2RP IV1303
Therapeutic area: Autoimmune & Inflammation
Cardiovascular and circulatory systems
Genetic Diseases and Dysmorphic syndromes
Infections
ENTRECHEM Brasilicardin analogs Biodrugs/ Drugs Autoimmune & Inflammation Immunosupression 1NRP Brasilicardin analogs
Therapeutic area: Autoimmune & Inflammation
ENTRECHEM EC-8042 iv for Ewing sarcoma Biodrugs/ Drugs Cancer Solid tumours 2RP EC-8042 iv for Ewing sarcoma
Therapeutic area: Cancer
ENTRECHEM EC-8042 iv for Triple negative breast cancer Biodrugs/ Drugs Cancer Triple negative breast cancer 2RP EC-8042 iv for Triple negative breast cancer
Therapeutic area: Cancer
ENTRECHEM EC-70124 po for TNBC Biodrugs/ Drugs Cancer Triple negative breast cancer 2RP EC-70124 po for TNBC
Therapeutic area: Cancer
ENTRECHEM EC-70124 po for prostate cancer Biodrugs/ Drugs Cancer Castration resistant prostate cancer 2RP EC-70124 po for prostate cancer
Therapeutic area: Cancer
ENTRECHEM EC-8042 iv for liposarcoma Biodrugs/ Drugs Cancer liposarcoma myxoide 2RP EC-8042 iv for liposarcoma
Therapeutic area: Cancer
ENTRECHEM EC-70124 po for AML Biodrugs/ Drugs Cancer Acute myeloid leukemia 2RP EC-70124 po for AML
Therapeutic area: Cancer
FERRER FAB-117 Gene / Cell Therapy Central Nervous System Spinal Cord Injury 4PhII FAB-117
Therapeutic area: Central Nervous System
FERRER FAB-120 Biodrugs/ Drugs Ophthalmology and optometry Diabetic Retinopathy 2RP FAB-120
Therapeutic area: Ophthalmology and optometry
FERRER SP1440 Biodrugs/ Drugs Central Nervous System Small Molecular. Schizophrenia and cognitive improvement 2RP SP1440
Therapeutic area: Central Nervous System
FUND. PROGRESO Y SALUD FISEVI-14012 Biodrugs/ Drugs Infections Multirresistant infections 2RP FISEVI-14012
Therapeutic area: Infections
FUND. PROGRESO Y SALUD Autologous Bone Marrow Mononuclear cells Gene / Cell Therapy Cardiovascular and circulatory systems
Metabolic / Endocrinology
Critical Limb Ischemia in diabetic patients 3PhI Autologous Bone Marrow Mononuclear cells
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
FUND. PROGRESO Y SALUD FISEVI-13020 Biodrugs/ Drugs Central Nervous System Alzheimer's disease 2RP FISEVI-13020
Therapeutic area: Central Nervous System
FUND. PROGRESO Y SALUD Autologous Bone Marrow Mononuclear cells Gene / Cell Therapy Cardiovascular and circulatory systems
Metabolic / Endocrinology
Acute Myocardial Infarction/Dilated Myocardiopathy/Chronic Ischemic Cardiopathy/Critical Limb Ischemia in diabetic & non patients 4PhII Autologous Bone Marrow Mononuclear cells
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
FUND. PROGRESO Y SALUD FISEVI-13007 Gene / Cell Therapy Cancer Hepatocarcinoma 2RP FISEVI-13007
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FIBAO-13014 Combination of Ketamine and Meperidine Biodrugs/ Drugs Autoimmune & Inflammation Mucositis 3PhI FIBAO-13014 Combination of Ketamine and Meperidine
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD CABIMER-14001 Condon plasma factors for skin regeneration Gene / Cell Therapy Autoimmune & Inflammation
Dermatology
Dermatitis 1NRP CABIMER-14001 Condon plasma factors for skin regeneration
Therapeutic area: Autoimmune & Inflammation
Dermatology
FUND. PROGRESO Y SALUD FISEVI 141 Biodrugs/ Drugs Infections Sepsis, Acute lung injury 2RP FISEVI 141
Therapeutic area: Infections
FUND. PROGRESO Y SALUD FIMABIS-14003 Biodrugs/ Drugs Dermatology
Infections
Treatment of mucocutaneous herpes infections 4PhII FIMABIS-14003
Therapeutic area: Dermatology
Infections
FUND. PROGRESO Y SALUD FRM-5 Gene / Cell Therapy Others Transplant 2RP FRM-5
Therapeutic area: Others
FUND. PROGRESO Y SALUD FIBAO-116 Biodrugs/ Drugs Analgesia & Pain Fibromyalgia 3PhI FIBAO-116
Therapeutic area: Analgesia & Pain
FUND. PROGRESO Y SALUD FISEVI-13002 Biodrugs/ Drugs Cancer Multiple myeloma 2RP FISEVI-13002
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD CABIMER-11 New target gene and delivery systems for the Treatment of Retinitis Pigmentosa Gene / Cell Therapy Ophthalmology and optometry Retinitis pigmentosa 1NRP CABIMER-11 New target gene and delivery systems for the Treatment of Retinitis Pigmentosa
Therapeutic area: Ophthalmology and optometry
FUND. PROGRESO Y SALUD FISEVI-121 Gene / Cell Therapy Autoimmune & Inflammation Transplant 2RP FISEVI-121
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD CABIMER-13003 Vaccines Central Nervous System Parkinson 1NRP CABIMER-13003
Therapeutic area: Central Nervous System
FUND. PROGRESO Y SALUD FIBAO-13007 Gene / Cell Therapy Cancer Cancer cells 2RP FIBAO-13007
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FIBICO-14003 Gene / Cell Therapy Musculoskeletal Disorders Musculoskeletal disorders 1NRP FIBICO-14003
Therapeutic area: Musculoskeletal Disorders
FUND. PROGRESO Y SALUD FIMABIS-99 Biodrugs/ Drugs Metabolic / Endocrinology Nanoemulsions for the treatment of obesity 2RP FIMABIS-99
Therapeutic area: Metabolic / Endocrinology
FUND. PROGRESO Y SALUD FIBICO-14002 Biodrugs/ Drugs Cancer Metastatic processes and resistant cancers 1NRP FIBICO-14002
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FIMABIS-77 Biodrugs/ Drugs Central Nervous System Hydroxytyrosol ethers 2RP FIMABIS-77
Therapeutic area: Central Nervous System
FUND. PROGRESO Y SALUD FIBAO-91 Melatonine Solution Biodrugs/ Drugs Infections Sepsis 4PhII FIBAO-91 Melatonine Solution
Therapeutic area: Infections
FUND. PROGRESO Y SALUD Allogeneic Adipose Mesenchymal stem cells / Allodepleted Bone Marrow Progenitors Biodrugs/ Drugs Autoimmune & Inflammation
Blood and Lymphatic systems
Chronic Graft versus Host Disease, Haematological Malignancies 4PhII Allogeneic Adipose Mesenchymal stem cells / Allodepleted Bone Marrow Progenitors
Therapeutic area: Autoimmune & Inflammation
Blood and Lymphatic systems
FUND. PROGRESO Y SALUD Engineered Corneas Gene / Cell Therapy Ophthalmology and optometry Corneal ulcers 4PhII Engineered Corneas
Therapeutic area: Ophthalmology and optometry
FUND. PROGRESO Y SALUD FIMABIS-13001 Biodrugs/ Drugs Metabolic / Endocrinology Treatment and/or Prevention of Non-alcoholic fatty liver disease (NAFLD) 2RP FIMABIS-13001
Therapeutic area: Metabolic / Endocrinology
FUND. PROGRESO Y SALUD Autologous Bone Marrow progenitors, Adipose and Bone Marrow Mesenchymal stem cells Gene / Cell Therapy Autoimmune & Inflammation
Central Nervous System
Stroke, Multiple Sclerosis and ALS 4PhII Autologous Bone Marrow progenitors, Adipose and Bone Marrow Mesenchymal stem cells
Therapeutic area: Autoimmune & Inflammation
Central Nervous System
FUND. PROGRESO Y SALUD FIMABIS-13007 Biodrugs/ Drugs Cardiovascular and circulatory systems
Metabolic / Endocrinology
Treatment and/or prevention of metabolic and cardiovascular diseases 2RP FIMABIS-13007
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
FUND. PROGRESO Y SALUD Autologous Bone Marrow Mononuclear cells and Adipose Mesenchymal stem cells Gene / Cell Therapy Digestive System Extended Liver resection, Faecal Incontinence 4PhII Autologous Bone Marrow Mononuclear cells and Adipose Mesenchymal stem cells
Therapeutic area: Digestive System
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) Mutli-target siRNA approach Gene / Cell Therapy Autoimmune & Inflammation
Kidney and Genitourinary system
Chronic Kidney Disease (CKD)/ Akute Kidney Injury (AKI) 2RP Mutli-target siRNA approach
Therapeutic area: Autoimmune & Inflammation
Kidney and Genitourinary system
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) New generation of peptides Biodrugs/ Drugs Autoimmune & Inflammation
Blood and Lymphatic systems
Cardiovascular and circulatory systems
Kidney and Genitourinary system
Metabolic / Endocrinology
Ophthalmology and optometry
Chronic complications of Diabetes / Choric kidney disease 2RP New generation of peptides
Therapeutic area: Autoimmune & Inflammation
Blood and Lymphatic systems
Cardiovascular and circulatory systems
Kidney and Genitourinary system
Metabolic / Endocrinology
Ophthalmology and optometry
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) Peptide derived from a natural compound Biodrugs/ Drugs Autoimmune & Inflammation
Metabolic / Endocrinology
Osteoporosis treatment 1NRP Peptide derived from a natural compound
Therapeutic area: Autoimmune & Inflammation
Metabolic / Endocrinology
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) Advanced cell therapies Gene / Cell Therapy Blood and Lymphatic systems
Cancer
Oncology / Haematological disorders 3PhI Spain / US Advanced cell therapies
Therapeutic area: Blood and Lymphatic systems
Cancer
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) Advanced cell therapies Gene / Cell Therapy Ophthalmology and optometry Eye rare diseases 4PhII Spain / Europe Advanced cell therapies
Therapeutic area: Ophthalmology and optometry
Fundacion MEDINA MDN-005 Biodrugs/ Drugs Central Nervous System
Musculoskeletal Disorders
Amyotrophic lateral sclerosis (ALS) 1NRP MDN-005
Therapeutic area: Central Nervous System
Musculoskeletal Disorders
Fundacion MEDINA MDN-057/MDN-058/MDN-059 Biodrugs/ Drugs Infections Gram negative infections 1NRP MDN-057/MDN-058/MDN-059
Therapeutic area: Infections
Fundacion MEDINA MDN-088 Biodrugs/ Drugs Cancer Breast, Colon & Lung Cancer 1NRP MDN-088
Therapeutic area: Cancer
Fundacion MEDINA MDN-0109, MDN-110, MDN-111, MDN- 112 Biodrugs/ Drugs Infections Malaria 1NRP MDN-0109, MDN-110, MDN-111, MDN- 112
Therapeutic area: Infections
Fundacion MEDINA MDN-018 Biodrugs/ Drugs Infections Fungal Infections 1NRP MDN-018
Therapeutic area: Infections
Fundacion MEDINA MDN-0145; MDN-0146 Biodrugs/ Drugs Central Nervous System Parkinson 1NRP MDN-0145; MDN-0146
Therapeutic area: Central Nervous System
Fundacion MEDINA MDN-0147; MDN-0148 & MDN-0149 Biodrugs/ Drugs Cancer Melanoma 1NRP MDN-0147; MDN-0148 & MDN-0149
Therapeutic area: Cancer
Fundacion MEDINA MDN-0090 Biodrugs/ Drugs Cancer Pancreatic Cancer 1NRP MDN-0090
Therapeutic area: Cancer
Highlight Therapeutics BO-112 Biodrugs/ Drugs Cancer Solid tumors Patients with liver metastasis from colorectal cancer or gastric/gastro-esophageal junction cancer 4PhII BO-112
Therapeutic area: Cancer
Histocell HC016 Biodrugs/ Drugs Central Nervous System Acute Spinal Cord Injury 4PhII HC016
Therapeutic area: Central Nervous System
Histocell HR004 Biodrugs/ Drugs Musculoskeletal Disorders Bone Regeneration 4PhII HR004
Therapeutic area: Musculoskeletal Disorders
Histocell HR016 Biodrugs/ Drugs Respiratory and Pulmonary system Acute Lung Injury 3PhI HR016
Therapeutic area: Respiratory and Pulmonary system
IIS La Fe Mutant of candida albicans and use in therapy against candidiasis Biodrugs/ Drugs Infections Mutant of candida albicans and use in therapy against candidiasis 1NRP Mutant of candida albicans and use in therapy against candidiasis
Therapeutic area: Infections
Institut Quimic de Sarrià (IQS) Chondro-implant Gene / Cell Therapy Cardiovascular and circulatory systems Bioactive implant for myocardial regeneration, ventricular support and elliptical shape restoration. Acute Cartilage Injure 1NRP Chondro-implant
Therapeutic area: Cardiovascular and circulatory systems
Institut Quimic de Sarrià (IQS) Cardio-implant Gene / Cell Therapy Cardiovascular and circulatory systems PCL (Polycaprolactone), SAP (self-assembling peptide) bioactive and biomimetic scaffolds for cartilage regeneration. Heart infarct 1NRP Cardio-implant
Therapeutic area: Cardiovascular and circulatory systems
Iproteos IPR-179 Biodrugs/ Drugs Central Nervous System Epilepsy 1NRP IPR-179
Therapeutic area: Central Nervous System
Iproteos IPR-166 Biodrugs/ Drugs Central Nervous System Cognitive Impairment associated to neurodegenerative and psychiatric diseases (schizophrenia, Parkinson's disease) 2RP Spain IPR-166
Therapeutic area: Central Nervous System
IRYCIS New compound for the treatment of isquemical stroke Biodrugs/ Drugs Central Nervous System Isquemic stroke 1NRP Spain New compound for the treatment of isquemical stroke
Therapeutic area: Central Nervous System
Laminar Pharma LP30171 Biodrugs/ Drugs Cancer
Metabolic / Endocrinology
Metabolic Diseases, cancer 1NRP LP30171
Therapeutic area: Cancer
Metabolic / Endocrinology
Laminar Pharma LP205A1 Biodrugs/ Drugs Cardiovascular and circulatory systems
Central Nervous System
Metabolic / Endocrinology
Cardiovascular and Metabolic Diseases, CNS, 1NRP LP205A1
Therapeutic area: Cardiovascular and circulatory systems
Central Nervous System
Metabolic / Endocrinology
Laminar Pharma LPA181 Biodrugs/ Drugs Central Nervous System Spinal Cord Injury, Pain. Global rigths outlicensed to a third party biotech company 2RP LPA181
Therapeutic area: Central Nervous System
Laminar Pharma LP561A1 Biodrugs/ Drugs Cancer Glioma and other solid tumours 4PhII LP561A1
Therapeutic area: Cancer
Laminar Pharma LP204A1 Biodrugs/ Drugs Autoimmune & Inflammation
Cardiovascular and circulatory systems
Inflammation, Cardiovascular 1NRP LP204A1
Therapeutic area: Autoimmune & Inflammation
Cardiovascular and circulatory systems
Laminar Pharma LP226A1 Biodrugs/ Drugs Central Nervous System Alzheimer's Disease 2RP LP226A1
Therapeutic area: Central Nervous System
Leukos Biotech LK-01 Biodrugs/ Drugs Blood and Lymphatic systems
Cancer
AML 3PhI LK-01
Therapeutic area: Blood and Lymphatic systems
Cancer
Minoryx MIN-102 (leriglitazone) Biodrugs/ Drugs Central Nervous System Friedreich's Ataxia 4PhII MIN-102 (leriglitazone)
Therapeutic area: Central Nervous System
Minoryx MIN-102 (leriglitazone) Biodrugs/ Drugs Central Nervous System
Kidney and Genitourinary system
Acute X-linked Adrenoleukodystrophy (cALD; cerebral ALD) 4PhII MIN-102 (leriglitazone)
Therapeutic area: Central Nervous System
Kidney and Genitourinary system
Minoryx MIN-102 (leriglitazone) Biodrugs/ Drugs Central Nervous System
Metabolic / Endocrinology
Chronic X-linked Adrenoleukodystrophy (AMN; Adrenomyeloneuropathy) 5PhIII MIN-102 (leriglitazone)
Therapeutic area: Central Nervous System
Metabolic / Endocrinology
NATAC Retriacyl Biodrugs/ Drugs Ophthalmology and optometry Retinitis Pigmentosa 5PhIII Europe Retriacyl
Therapeutic area: Ophthalmology and optometry
Neurofix NFX91 Biodrugs/ Drugs Others Sleep disorders 1NRP NFX91
Therapeutic area: Others
Neurofix NFX88 Biodrugs/ Drugs Analgesia & Pain
Central Nervous System
Neuropathic pain 4PhII Spain NFX88
Therapeutic area: Analgesia & Pain
Central Nervous System
Neurofix NFX81 Biodrugs/ Drugs Central Nervous System Spinal Cord Injuries 2RP Spain NFX81
Therapeutic area: Central Nervous System
ONA Therapeutics ONA-1 Biodrugs/ Drugs Cancer Advanced cancer 1NRP ONA-1
Therapeutic area: Cancer
Oryzon ORY-2001 Biodrugs/ Drugs Central Nervous System Alzheimer's disease (Mild Moderate) 4PhII ORY-2001
Therapeutic area: Central Nervous System
Oryzon ORY-1001 Biodrugs/ Drugs Cancer Small-cell lung cancer 4PhII ORY-1001
Therapeutic area: Cancer
Oryzon ORY-2001 Biodrugs/ Drugs Central Nervous System Multiple Sclerosis (Relapse Remitting & Secondary Progressive) 4PhII ORY-2001
Therapeutic area: Central Nervous System
Oryzon ORY-1001 Biodrugs/ Drugs Blood and Lymphatic systems
Cancer
Acute myeloid leukemia (AML) 4PhII ORY-1001
Therapeutic area: Blood and Lymphatic systems
Cancer
Oryzon ORY-1001 Biodrugs/ Drugs Cancer Small-cell lung cancer 4PhII ORY-1001
Therapeutic area: Cancer
Oryzon OG-new series in KDM Biodrugs/ Drugs Cancer
Others
Solid cancers, Oncohaematology 1NRP OG-new series in KDM
Therapeutic area: Cancer
Others
Oryzon ORY-2001 Biodrugs/ Drugs Central Nervous System CNS Basket Trial Aggression 4PhII ORY-2001
Therapeutic area: Central Nervous System
Oryzon ORY-3001 Biodrugs/ Drugs Others Non-oncological disease 2RP ORY-3001
Therapeutic area: Others
PaloBiofarma PBF-677 Biodrugs/ Drugs Digestive System Colitis 4PhII Spain PBF-677
Therapeutic area: Digestive System
PaloBiofarma PBF-999 Biodrugs/ Drugs Cancer Solid Tumors 3PhI Spain PBF-999
Therapeutic area: Cancer
PaloBiofarma PBF-509 Biodrugs/ Drugs Cancer
Central Nervous System
Lung Cancer 4PhII Spain PBF-509
Therapeutic area: Cancer
Central Nervous System
PaloBiofarma PBF680 Biodrugs/ Drugs Respiratory and Pulmonary system Asthma 4PhII Spain PBF680
Therapeutic area: Respiratory and Pulmonary system
PaloBiofarma PBF-1129 Biodrugs/ Drugs Cancer Lung Cancer 3PhI Spain PBF-1129
Therapeutic area: Cancer
Peptomyc OMO-103 Biodrugs/ Drugs Cancer Therapy for NSCLC and breast cancer. 2RP Spain OMO-103
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) Biodrugs/ Drugs Cancer BRCA+Breast Cancer 4PhII LURBINECTEDIN (PM1183)
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) Biodrugs/ Drugs Cancer Solid tumors 4PhII EU & NA LURBINECTEDIN (PM1183)
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) Biodrugs/ Drugs Cancer Endometrial cancer 4PhII EU & NA LURBINECTEDIN (PM1183)
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) Biodrugs/ Drugs Cancer Small Cell Lung Cancer 4PhII EU & NA LURBINECTEDIN (PM1183)
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) + CPT 11 Biodrugs/ Drugs Cancer Solid Tumors 4PhII LURBINECTEDIN (PM1183) + CPT 11
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) Biodrugs/ Drugs Cancer Mesothelioma 4PhII LURBINECTEDIN (PM1183)
Therapeutic area: Cancer
PharmaMar PM184 Biodrugs/ Drugs Cancer Solid tumors 3PhI EU & NA PM184
Therapeutic area: Cancer
PharmaMar PM14 Biodrugs/ Drugs Cancer Solid tumors 3PhI EU PM14
Therapeutic area: Cancer
PharmaMar TRABECTEDIN + PLD Biodrugs/ Drugs Cancer Ovarian Cancer. 5PhIII Europe TRABECTEDIN + PLD
Therapeutic area: Cancer
PharmaMar TRABECTEDIN + PLD Biodrugs/ Drugs Cancer Ovarian cancer (Japan) 3PhI Japan TRABECTEDIN + PLD
Therapeutic area: Cancer
PharmaMar TRABECTEDIN + Radiotherapy Biodrugs/ Drugs Cancer Sarcoma 4PhII Europe TRABECTEDIN + Radiotherapy
Therapeutic area: Cancer
PharmaMar TRABECTEDIN Biodrugs/ Drugs Cancer Retroperitoneal L-Sarcoma 4PhII Italy TRABECTEDIN
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) Biodrugs/ Drugs Cancer Solid tumors 3PhI Japan LURBINECTEDIN (PM1183)
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) + DOXORUBICIN Biodrugs/ Drugs Cancer Small Cell lung cancer 5PhIII EU , LA & LATAM LURBINECTEDIN (PM1183) + DOXORUBICIN
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) Biodrugs/ Drugs Cancer Ewing Sarcoma 4PhII EU & NA LURBINECTEDIN (PM1183)
Therapeutic area: Cancer
REIG JOFRE P0265 Biodrugs/ Drugs Dermatology Skin infections 5PhIII Spain, Mexico P0265
Therapeutic area: Dermatology
REIG JOFRE P0223 Biodrugs/ Drugs Dermatology Skin infection 6Reg. Spain P0223
Therapeutic area: Dermatology
Sanifit SNF472 Biodrugs/ Drugs Cardiovascular and circulatory systems
Metabolic / Endocrinology
Calciphylaxis 5PhIII SNF472
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
Sanifit SNF472 Biodrugs/ Drugs Cardiovascular and circulatory systems
Metabolic / Endocrinology
Peripheral Arterial Disease (dialysis) 5PhIII SNF472
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
SOM Biotech SOM0044 Biodrugs/ Drugs Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Parkinson’s disease 2RP SOM0044
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
SOM Biotech SOM3355 Biodrugs/ Drugs Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Chorea in Huntington's disease 5PhIII Spain SOM3355
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
SOM Biotech SOM0208 Biodrugs/ Drugs Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Metabolic / Endocrinology
Niemann-Pick 2RP SOM0208
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Metabolic / Endocrinology
SOM Biotech SOM0061 Biodrugs/ Drugs Infections
Respiratory and Pulmonary system
COVID-19 4PhII SOM0061
Therapeutic area: Infections
Respiratory and Pulmonary system
SOM Biotech SOM1311 Biodrugs/ Drugs Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Metabolic / Endocrinology
Phenylketonuria 2RP SOM1311
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Metabolic / Endocrinology
Sylentis siRNA / SYL1801 Biodrugs/ Drugs Ophthalmology and optometry Retina 2RP siRNA / SYL1801
Therapeutic area: Ophthalmology and optometry
Sylentis Tivanisirán / SYL1001 Biodrugs/ Drugs Ophthalmology and optometry Dry Eye Syndrome 5PhIII Tivanisirán / SYL1001
Therapeutic area: Ophthalmology and optometry
Sylentis Bamosiran / SYL040012 Biodrugs/ Drugs Ophthalmology and optometry Ocular Hypertension, Glaucoma 4PhII Bamosiran / SYL040012
Therapeutic area: Ophthalmology and optometry
Thrombotargets TT-112 Biodrugs/ Drugs Blood and Lymphatic systems Antifibrinolysis 1NRP TT-112
Therapeutic area: Blood and Lymphatic systems
Thrombotargets TT-173 Biodrugs/ Drugs Blood and Lymphatic systems Haemorrhage 5PhIII TT-173
Therapeutic area: Blood and Lymphatic systems
VCN Biosciences VCN-11 Gene / Cell Therapy Cancer Solid Tumors 2RP VCN-11
Therapeutic area: Cancer
VCN Biosciences VCN-02 Gene / Cell Therapy Cancer Solid Tumors 1NRP VCN-02
Therapeutic area: Cancer
VENTER PHARMA LacTEST 0,45 g Biodrugs/ Drugs Digestive System Evaluation of hypolactasia 6Reg. LacTEST 0,45 g
Therapeutic area: Digestive System
VENTER PHARMA LacTEST 2,7 g Biodrugs/ Drugs Digestive System Evaluation of hypolactasia 5PhIII LacTEST 2,7 g
Therapeutic area: Digestive System
Vivia Biotech Vivia 009 Biodrugs/ Drugs Blood and Lymphatic systems
Central Nervous System
Non Hodgkin Lymphoma, CNS 2RP Europe Vivia 009
Therapeutic area: Blood and Lymphatic systems
Central Nervous System
Vivia Biotech Vivia 011 Biodrugs/ Drugs Metabolic / Endocrinology Obesity, Diabetes 1NRP Vivia 011
Therapeutic area: Metabolic / Endocrinology
ZENDAL MTBVAC Vaccines Infections
Respiratory and Pulmonary system
MTBVAC is a live freeze dried vaccine based on a genetically attenuated strain of a clinical isolate of M. tuberculosis manufactured by BIOFABRI. MTBVAC is now in Phase 2a in newborns infants and a Phase2a in BCG-vaccinated adults in South Africa 4PhII MTBVAC
Therapeutic area: Infections
Respiratory and Pulmonary system